Leading in Crisis is a practical guide for pharmaceutical and biotech leaders navigating high-stakes environments where science, ethics, patient trust, and operational continuity collide.
In the pharmaceutical and biotechnology industries, crises are not hypotheticalāthey are inevitable. Clinical trial setbacks, safety signals, regulatory scrutiny, supply chain disruptions, pricing controversies, and digital reputational risks can emerge suddenly, placing immense pressure on leaders and organizations alike.
Through real-world examples and actionable models, this book explores how leaders can master crisis communication, build effective response teams, uphold scientific integrity, and maintain patient-centric and ethical governanceāeven in moments of intense scrutiny. It addresses the growing impact of digital media, emerging risks such as AI and cybersecurity, and the evolving role of Medical Affairs as a strategic leader during disruption.
More than a management handbook, Leading in Crisis is a blueprint for leaders who aspire to transform adversity into clarity, credibility, and long-term strengthāwhile never losing sight of the patients and principles that define their mission.